Company intelligence / Profile preview

Heumann Pharma

Nürnberg, Bayern, Germanyheumann.de ↗
Ownership
Private
Development stage
Commercial
01

Overview

As of 2023, over 16 million packs of Heumann prescription medicines were distributed to patients[2]

Therapeutic areas
Other
Modalities
Generic medicinesprescription medicinesover-the-counter medicines
Industry
Biotech
02

Drug pipeline

1 asset

Resultz

Commercial
Indications
Head lice infestation
03

Partnerships

Contracts with statutory and private health insurance companies for about 86% of their prescription medicines[2]

Beyond the preview

Go deeper on Heumann Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heumann Pharma.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call